We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+4.71%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$9.44B
AUM Growth
+$1.08B
(+13%)
Cap. Flow
+$1.04B
Cap. Flow
% of AUM
11.03%
Top 10 Holdings %
Top 10 Hldgs %
56.7%
Holding
92
New
16
Increased
26
Reduced
14
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$112M |
| 2 |
Zoom
ZM
|
+$83.8M |
| 3 |
Gildan
GIL
|
+$73.7M |
| 4 |
Edgewell Personal Care
EPC
|
+$60.3M |
| 5 |
Amcor
AMCR
|
+$56.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$298M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$196M |
| 3 |
Fluor
FLR
|
+$164M |
| 4 |
Roivant Sciences
ROIV
|
+$103M |
| 5 |
Vistra
VST
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Utilities | 19.69% |
| 3 | Industrials | 9.76% |
| 4 | Energy | 6.79% |
| 5 | Communication Services | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Helen of Troy
HELE
$655M
| $5.28M | 0.06% |
366,226
+109,289
| +43% | +$1.91M |
|
|
MREO
77
Mereo BioPharma
MREO
$49.4M
| $5.05M | 0.05% |
15,307,347
| – | – |
|
|
EPRX
78
Eupraxia Pharmaceuticals
EPRX
$413M
| $5M | 0.05% |
+691,170
| New | +$5.56M |
|
79
PennyMac Financial
PFSI
$4.32B
| $4.78M | 0.05% |
+54,727
| New | +$5.89M |
|
80
Edesa Biotech
EDSA
$59.9M
| $3.6M | 0.04% |
687,500
| – | – |
|
81
TherapeuticsMD
TXMD
$23.8M
| $2.41M | 0.03% |
1,192,191
| – | – |
|
82
PLAYSTUDIOS Inc
MYPS
$106M
| $1.27M | 0.01% |
2,697,384
| – | – |
|
83
Archer Daniels Midland
ADM
$41.4B
| – | – |
-1,101,583
| Closed | -$63.3M |
|
84
Bunge Global
BG
$23.3B
| – | – |
-676,510
| Closed | -$60.3M |
|
85
Darling Ingredients
DAR
$10.1B
| – | – |
-680,827
| Closed | -$24.5M |
|
86
Eos Energy Enterprises
EOSE
$1.44B
| – | – |
-6,500,000
| Closed | -$74.5M |
|
|
87
Fluor
FLR
$6.99B
| – | – |
-4,143,808
| Closed | -$164M |
|
88
Graphic Packaging
GPK
$3.22B
| – | – |
-2,000,000
| Closed | -$30.1M |
|
89
New Fortress Energy
NFE
$95M
| – | – |
-23,701,399
| Closed | -$27M |
|
|
SW
90
Smurfit Westrock
SW
$22.7B
| – | – |
-400,000
| Closed | -$15.5M |
|
|
STUB
91
StubHub Holdings
STUB
$3.45B
| – | – |
-784,854
| Closed | -$10.6M |
|
Similar funds
SCM
RCM
AIM
MIF
SIM
NPT
AC
PVI
Rubric Capital Management (New York)'s Q1 2026 Portfolio in Review
As of Q1 2026, Rubric Capital Management (New York) held 92 positions worth $9.44B, up 13% from $8.36B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Rubric Capital Management (New York) deployed $1.04B of net new capital in Q1 2026, opening 16 new positions and adding to 26 existing holdings. Its largest new stake was Zoom: 1,001,006 shares worth $80.5M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 33% a quarter earlier, followed by Utilities and Industrials.
On the sell side, the largest reduction was FTAI Aviation, an estimated $298M trimmed.
- Rubric Capital Management (New York)'s largest Q1 2026 buy was Zoom: 1,001,006 shares worth $80.5M.
- Rubric Capital Management (New York) added most to Viatris in Q1 2026, an estimated $112M increase.
- Rubric Capital Management (New York)'s biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $298M.
- Rubric Capital Management (New York) fully exited Fluor in Q1 2026, selling an estimated $164M.
- Rubric Capital Management (New York)'s ten largest holdings make up 57% of its $9.44B portfolio in Q1 2026.
- Rubric Capital Management (New York) opened 16 new positions and closed 9 in Q1 2026.
- Rubric Capital Management (New York)'s portfolio value rose 13% quarter-over-quarter to $9.44B.
Based on Rubric Capital Management (New York)'s 13F filing for Q1 2026, filed 15 May 2026.